학술논문

Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study
Document Type
article
Source
Respiratory Research, Vol 23, Iss 1, Pp 1-13 (2022)
Subject
Restricted spirometry
Lung function impairment
Cardiovascular disease
Hypertension
Diabetes
Comorbidity
Diseases of the respiratory system
RC705-779
Language
English
ISSN
1465-993X
Abstract
Abstract Background Whether restricted spirometry, i.e. low Forced Vital Capacity (FVC), predicts chronic cardiometabolic disease is not definitely known. In this international population-based study, we assessed the relationship between restricted spirometry and cardiometabolic comorbidities. Methods A total of 23,623 subjects (47.5% males, 19.0% current smokers, age: 55.1 ± 10.8 years) from five continents (33 sites in 29 countries) participating in the Burden of Obstructive Lung Disease (BOLD) study were included. Restricted spirometry was defined as post-bronchodilator FVC